Trump Administration Cuts Funding for HIV Vaccine Research: Scientists Express Outrage

The Trump administration's decision to cut funding for HIV vaccine research has sparked controversy within the scientific community. The cuts, impacting major research efforts at Duke and Scripps Research Institutes, are viewed as a significant setback for HIV vaccine development. "This is a massive setback," stated one scientist interviewed in the CBS Mornings report. The administration argues that current efforts are sufficient, but scientists disagree, highlighting the unique challenges of HIV and the ongoing need for research. The decision underscores the political complexities of scientific funding and the potential consequences for public health initiatives. Despite the setback, researchers remain committed to finding a vaccine, emphasizing the ongoing hope for a future where HIV is preventable.